Current Neuro-Oncology


Volume 24 Number 21
15 November 2022


Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 21, 15 November






Wang E, Gutkin PM, Oh J, Pollom E, Soltys SG, Grant GA, Prolo LM, Chang S, Li G, Fisher PG, Partap S, Campen CJ, Gibbs IC, Hiniker SM.
Stereotactic radiosurgery for recurrent pediatric brain tumors: clinical outcomes and toxicity.
Neurosurg Focus. 2022 Nov;53(5):E2. doi: 10.3171/2022.8.FOCUS22361. PMID: 36321285. Observational study.




Chen X, Momin A, Wanggou S, Wang X, Min HK, Dou W, Gong Z, Chan J, Dong W, Fan JJ, Xiong Y, Talipova K, Zhao H, Chen YX, Veerasammy K, Fekete A, Kumar SA, Liu H, Yang Q, Son JE, Dou Z, Hu M, Pardis P, Juraschka K, Donovan LK, Zhang J, Ramaswamy V, Selvadurai HJ, Dirks PB, Taylor MD, Wang LY, Hui CC, Abzalimov R, He Y, Sun Y, Li X, Huang X.
Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity.
Neuron. 2022 Nov 1, 2022:S0896-6273(22)00911-4. doi: 10.1016/j.neuron.2022.10.007. PMID: 36323321. Laboratory investigation.




Liu Y, Chen H, Li G, Zhang J, Yao K, Wu C, Li S, Qiu X.
Radiotherapy delays malignant transformation and prolongs survival in patients with IDH-mutant gliomas.
Cancer Biol Med. 2022 Nov 1, 2022;19(10):1477–86. doi: 10.20892/j.issn.2095-3941.2022.0472. PMID: 36350001. Observational study.




Fernandez-Gil BI, Otamendi-Lopez A, Bechtle A, Vazquez-Ramos CA, Qosja N, Suarez-Meade P, Sarabia-Estrada R, Jentoft ME, Guerrero-Cázares H, Escames G, Schiapparelli P, Quiñones-Hinojosa A.
Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma.
Cells. 2022 Nov 2, 2022;11(21):3467. doi: 10.3390/cells11213467. PMID: 36359862. Laboratory investigation.




Smith K, Nakaji P, Thomas T, Pinnaduwage D, Wallstrom G, Choi M, Zabramski J, Chen C, Brachman D.
Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: Results from a prospective trial.
Neuro Oncol. 2022 Nov 2, 2022;24(S6):S4-S15. doi: 10.1093/neuonc/noac133. PMID: 36322102. Interventional study.




Forster MT, Hug M, Geissler M, Voss M, Weber K, Hoelter MC, Seifert V, Czabanka M, Steinbach JP.
Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatment.
J Cancer Res Clin Oncol. 2022 Nov 8. doi: 10.1007/s00432-022-04439-7. PMID: 36348019. Observational study.




Ali AS, Lombardo J, Niazi MZ, Miller RC, Alnahhas I, Martinez NL, Andrews DW, Judy KD, Shi W.
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study.
J Neurooncol. 2022 Nov 10. doi: 10.1007/s11060-022-04146-w. PMID: 36355259. Interventional study˰



*

Girardi F, Matz M, Stiller C, You H, Marcos Gragera R, Valkov MY, Bulliard JL, De P, Morrison D, Wanner M, O'Brian DK, Saint-Jacques N, Coleman MP, Allemani C; CONCORD Working Group.
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3).
Neuro Oncol. 2022 Nov 10, 2022:noac217. doi: 10.1093/neuonc/noac217. PMID: 36355361. Observational study.




Hazaymeh M, Löber-Handwerker R, Döring K, Abboud T, Mielke D, Rohde V, Malinova V.
Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.
Sci Rep. 2022 Nov 10, 2022;12(1):19208. doi: 10.1038/s41598-022-23794-6. PMID: 36357498. Observational study.




Wang J, Huang Y, Zhao F, Chen J, He L, Liu Z, Pei Y, Wei Z, Li R, Ai P, Peng X.
Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis.
J Neurooncol. 2022 Nov 10. doi: 10.1007/s11060-022-04162-w. PMID: 36357822. Observational study˰